BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17603841)

  • 1. The cotton rat as a model to study influenza pathogenesis and immunity.
    Eichelberger MC
    Viral Immunol; 2007; 20(2):243-9. PubMed ID: 17603841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a cross-protective immune response to influenza A in the cotton rat model.
    Straight TM; Ottolini MG; Prince GA; Eichelberger MC
    Vaccine; 2006 Sep; 24(37-39):6264-71. PubMed ID: 16860444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.
    Ottolini MG; Blanco JCG; Eichelberger MC; Porter DD; Pletneva L; Richardson JY; Prince GA
    J Gen Virol; 2005 Oct; 86(Pt 10):2823-2830. PubMed ID: 16186238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains.
    Blanco JC; Pletneva LM; Wan H; Araya Y; Angel M; Oue RO; Sutton TC; Perez DR
    J Virol; 2013 Feb; 87(4):2036-45. PubMed ID: 23192875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza and Antibody-Dependent Cellular Cytotoxicity.
    Von Holle TA; Moody MA
    Front Immunol; 2019; 10():1457. PubMed ID: 31316510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza B viruses: not to be discounted.
    van de Sandt CE; Bodewes R; Rimmelzwaan GF; de Vries RD
    Future Microbiol; 2015; 10(9):1447-65. PubMed ID: 26357957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evasion of influenza A viruses from innate and adaptive immune responses.
    van de Sandt CE; Kreijtz JH; Rimmelzwaan GF
    Viruses; 2012 Sep; 4(9):1438-76. PubMed ID: 23170167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract.
    Mifsud EJ; Kuba M; Barr IG
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One step closer to universal influenza epitopes.
    Li OT; Poon LL
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):687-90. PubMed ID: 19681695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host species barriers to influenza virus infections.
    Kuiken T; Holmes EC; McCauley J; Rimmelzwaan GF; Williams CS; Grenfell BT
    Science; 2006 Apr; 312(5772):394-7. PubMed ID: 16627737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
    Eichelberger MC; Prince GA; Ottolini MG
    Virology; 2004 May; 322(2):300-7. PubMed ID: 15110527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and mucosal isotype-specific antibody responses in pigs to experimental influenza virus infection.
    Heinen PP; van Nieuwstadt AP; Pol JM; de Boer-Luijtze EA; van Oirschot JT; Bianchi AT
    Viral Immunol; 2000; 13(2):237-47. PubMed ID: 10893003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protective immunity to influenza A viruses.
    Epstein SL; Price GE
    Expert Rev Vaccines; 2010 Nov; 9(11):1325-41. PubMed ID: 21087110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
    Qi X; Lu C
    Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell mediated immunity to influenza: mechanisms of viral control.
    La Gruta NL; Turner SJ
    Trends Immunol; 2014 Aug; 35(8):396-402. PubMed ID: 25043801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of and immunity to avian influenza A H5 viruses.
    Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM
    Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.